157 related articles for article (PubMed ID: 8893266)
1. Differential effect of taxol in rat primary and metastatic prostate tumors: site-dependent pharmacodynamics.
Yen WC; Wientjes MG; Au JL
Pharm Res; 1996 Sep; 13(9):1305-12. PubMed ID: 8893266
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics of taxol in human head and neck tumors.
Gan Y; Wientjes MG; Schuller DE; Au JL
Cancer Res; 1996 May; 56(9):2086-93. PubMed ID: 8616855
[TBL] [Abstract][Full Text] [Related]
3. Mdr1 transfection causes enhanced apoptosis by paclitaxel: an effect independent of drug efflux function of P-glycoprotein.
Li D; Au JL
Pharm Res; 2001 Jul; 18(7):907-13. PubMed ID: 11496948
[TBL] [Abstract][Full Text] [Related]
4. Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance.
Vredenburg MR; Ojima I; Veith J; Pera P; Kee K; Cabral F; Sharma A; Kanter P; Greco WR; Bernacki RJ
J Natl Cancer Inst; 2001 Aug; 93(16):1234-45. PubMed ID: 11504769
[TBL] [Abstract][Full Text] [Related]
5. Cytostatic and apoptotic effects of paclitaxel in human ovarian tumors.
Millenbaugh NJ; Gan Y; Au JL
Pharm Res; 1998 Jan; 15(1):122-7. PubMed ID: 9487558
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance phenotype and paclitaxel (Taxol) sensitivity in human renal carcinoma cell lines of different histologic types.
Reinecke P; Schmitz M; Schneider EM; Gabbert HE; Gerharz CD
Cancer Invest; 2000; 18(7):614-25. PubMed ID: 11036469
[TBL] [Abstract][Full Text] [Related]
7. Cytostatic and apoptotic effects of paclitaxel in human breast tumors.
Gan Y; Wientjes MG; Lu J; Au JL
Cancer Chemother Pharmacol; 1998; 42(3):177-82. PubMed ID: 9685052
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line.
Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH
Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763
[TBL] [Abstract][Full Text] [Related]
9. Determinants of paclitaxel uptake, accumulation and retention in solid tumors.
Jang SH; Wientjes MG; Au JL
Invest New Drugs; 2001 May; 19(2):113-23. PubMed ID: 11392446
[TBL] [Abstract][Full Text] [Related]
10. Induction of thymidine phosphorylase expression by Taxol does not enhance Furtulon sensitivity in a cisplatin-resistant human ovarian carcinoma cell line.
Hata K; Osaki M; Kanasaki H; Nakayama K; Fujiwaki R; Ito H; Miyazaki K
Anticancer Res; 2003; 23(2B):1525-31. PubMed ID: 12820419
[TBL] [Abstract][Full Text] [Related]
11. Taxol-induced cell cycle arrest and apoptosis: dose-response relationship in lung cancer cells of different wild-type p53 status and under isogenic condition.
Das GC; Holiday D; Gallardo R; Haas C
Cancer Lett; 2001 Apr; 165(2):147-53. PubMed ID: 11275363
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA; Vellon L; Colomer R; Lupu R
Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
[TBL] [Abstract][Full Text] [Related]
13. Relationship between paclitaxel activity and pathobiology of human solid tumors.
Gan Y; Wientjes MG; Au JL
Clin Cancer Res; 1998 Dec; 4(12):2949-55. PubMed ID: 9865905
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of taxol resistance via P-glycoprotein- and non-P-glycoprotein-mediated mechanisms in human ovarian carcinoma cells.
Parekh H; Wiesen K; Simpkins H
Biochem Pharmacol; 1997 Feb; 53(4):461-70. PubMed ID: 9105396
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of COX-2 and multidrug resistance between primary tumors and regional lymph node metastases of gastric cancer.
Li Y; Tan BB; Fan LQ; Zhao Q; Liu Y; Wang D
Tumori; 2012; 98(4):516-22. PubMed ID: 23052170
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic effects of paclitaxel in human bladder tumors.
Au JL; Kalns J; Gan Y; Wientjes MG
Cancer Chemother Pharmacol; 1997; 41(1):69-74. PubMed ID: 9443616
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a taxol-resistant human small-cell lung cancer cell line.
Ohta S; Nishio K; Kubota N; Ohmori T; Funayama Y; Ohira T; Nakajima H; Adachi M; Saijo N
Jpn J Cancer Res; 1994 Mar; 85(3):290-7. PubMed ID: 7514586
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a human myeloid leukemia cell line highly resistant to taxol.
Bhalla K; Huang Y; Tang C; Self S; Ray S; Mahoney ME; Ponnathpur V; Tourkina E; Ibrado AM; Bullock G
Leukemia; 1994 Mar; 8(3):465-75. PubMed ID: 7907395
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
Chang CJ; Ghosh PK; Hu YF; Brueggemeier RW; Lin YC
Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):293-312. PubMed ID: 8480076
[TBL] [Abstract][Full Text] [Related]
20. [Expression and significance of heparin binding-epidermal growth factor-like growth factor in paclitaxel-resistant ovarian cancer].
Tang X; Lu M; Li C; Deng S; Li M
Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):517-22. PubMed ID: 25327734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
